https://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-volatility-impacts-ipos-in-the-us-but-biopharma-is-a-standout-SG5LQH7FXVAH5LCDMQK3NYSNKY/2026-04-06T23:23:34.851Zalways0.5Insightsen2026-04-06T23:23:34.851Zhttps://insights.citeline.com/resizer/QP0XsTOKIkbEiMw2sxA1vTD-XIs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UUPCCTOSUNI7ZKUU3DO7RIZNHI.jpghttps://insights.citeline.com/pink-sheet/legislation/direct-to-consumer-advertising-ind-reform-top-us-fdas-wish-list-for-statutory-changes-5OP7WXP3C5DXJBVFHKBMQ5E72Y/2026-04-06T22:24:12.969Zalways0.5Insightsen2026-04-06T22:24:12.969Zhttps://insights.citeline.com/resizer/hvz3XCQaNSM9wYnQcBwaGtSqf6w=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3GZNN6YOEZDQDJZSFZELYI5K7M.jpghttps://insights.citeline.com/pink-sheet/pathways-and-standards/user-fees/us-fdas-fy-2027-budget-proposes-non-user-fee-funding-cuts-adds-fee-protection-dollars-XNOHGCCKAFG5VCWZFMSGI6NRIY/2026-04-06T22:23:37.656Zalways0.5Insightsen2026-04-06T22:23:37.656Zhttps://insights.citeline.com/resizer/NgpERL5NyUq9GQgouweJ1L4S2Cg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GXY2IJ5AUBECXK7IUNAR5WU7ME.jpghttps://insights.citeline.com/pink-sheet/agency-leadership/us-fda/the-next-cber-director-will-us-fda-hire-a-new-face-career-scientist-or-caretaker-GF4EM6XCZFGLVHHUY7GYOOZMBA/2026-04-06T22:23:24.43Zalways0.5Insightsen2026-04-06T22:23:24.43Zhttps://insights.citeline.com/resizer/ptjcFpvEKaBwLCAAXx8ZYL-q_eg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BQZAP4OVOVEEVJ2IKTHNCR7TVA.jpghttps://insights.citeline.com/pink-sheet/r-and-d/clinical-trials/ambros-aims-to-revive-neridronate-for-crps-with-precision-medicine-GNWR34AG7RC2DFJPZZ2RZXRRBQ/2026-04-06T22:16:47.693Zalways0.5Insightsen2026-04-06T22:16:47.693Zhttps://insights.citeline.com/resizer/C8MT8e5TA694KUvjWixt7szDmqc=/cloudfront-us-east-1.images.arcpublishing.com/norstella/DBKZ3TY6VNHM5KJGG3FZSGFVXQ.jpghttps://insights.citeline.com/medtech-insight/business/r-and-d/clinical-trials/bci-maker-epia-neuro-bets-on-intent-driven-rehab-for-stroke-patients-with-implant-glove-MT6EQD2RDZE3HGMKCQYJOF623A/2026-04-06T22:12:01.626Zalways0.5Insightsen2026-04-06T22:12:01.626Zhttps://insights.citeline.com/resizer/btrVoq1Hi7HxX_Ih73HbStxdvV8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/CUG2CVO4OZHSPK5XZMCU7UXLWE.pnghttps://insights.citeline.com/scrip/business/financing/venture-funding-keeps-a-steady-pace-in-q1-YCRVNSKYFBHKJMBV5U5Y3S5QMQ/2026-04-06T22:09:19.463Zalways0.5Insightsen2026-04-06T22:09:19.463Zhttps://insights.citeline.com/resizer/-MvP7RFMhU673w3_Npj1Y3atduk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/Y5HEYZ3PA5DHFJPHH3KTX3QSWM.jpghttps://insights.citeline.com/scrip/business/deals/neurocrine-takes-sensible-way-into-metabolic-disease-with-29bn-soleno-buy-FQXVQVK42JFFPPTAFOWUMUUF4I/2026-04-06T21:55:55.502Zalways0.5Insightsen2026-04-06T21:55:55.502Zhttps://insights.citeline.com/resizer/nh_on7YonoFG7JpVOaqM50mNx0E=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IHOPBJJEW5IRFP5CRAA2NYN73M.jpghttps://insights.citeline.com/scrip/business/deals/five-more-things-to-know-about-neurocrines-29bn-bid-for-soleno-E7IKKQ2I7JH3XKPFEVKLKFTZDY/2026-04-06T21:47:29.292Zalways0.5Insightsen2026-04-06T21:47:29.292Zhttps://insights.citeline.com/resizer/6d3nKSaUpyMymFvDFJrUpuLn1k4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/APCQNKIM7ZARHNGEM6TVLGPOV4.jpghttps://insights.citeline.com/scrip/r-and-d/pipeline-watch/pipeline-watch-thirteen-approvals-and-eighteen-phase-iii-readouts-NDXHAPUVAFBZPD67OWOQZRKTB4/2026-04-06T21:21:26.621Zalways0.5Insightsen2026-04-06T21:21:26.621Zhttps://insights.citeline.com/resizer/ImR5GTpVdBHGHf7TcvS_mtsKATo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ESZMBZ2PYRKC7MS7AXLRQU4VXA.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/amgens-subcutaneous-tepezza-scores-in-ted-as-more-convenient-version-IN4OB5DL7BGFRISG3YRENKDRCQ/2026-04-06T21:21:11.63Zalways0.5Insightsen2026-04-06T21:21:11.63Zhttps://insights.citeline.com/resizer/tbjM4_1AUmiLP3jyU0DQuzcex58=/cloudfront-us-east-1.images.arcpublishing.com/norstella/CAZ4MIIYCBAVVFZ7DACUCIMAC4.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/compliance/us-fda-warning-letters/us-fda-warning-letters-february-march-2026-FBJH3X4JBFEDJPTJGMIZWBNXFM/2026-04-06T19:51:32.037Zalways0.5Insightsen2026-04-06T19:51:32.037Zhttps://insights.citeline.com/resizer/zLT39Ifn0Ttr7kumFj1HsmBx5oM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/RQCP5NIPKNAHTFWUGBRPBV7APU.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/recalls/philips-recalls-thousands-of-x-ray-systems-due-to-device-design-malfunction-2AJJPASRNRHPVGQPZEDBC2FQ4I/2026-04-06T19:31:12.53Zalways0.5Insightsen2026-04-06T19:31:12.53Zhttps://insights.citeline.com/resizer/g9wry9Gv7OpPBIJdTRW6AkZYR9U=/cloudfront-us-east-1.images.arcpublishing.com/norstella/NXTZQ7GPSVBF5L6QJRDQVDDDOA.jpghttps://insights.citeline.com/scrip/leadership/interviews/acadia-ceo-led-the-company-to-a-key-goal-in-a-challenging-year-for-biopharma-FEW7E57XUNCZRLEF3QONFTSSTE/2026-04-06T17:54:34.638Zalways0.5Insightsen2026-04-06T17:54:34.638Zhttps://insights.citeline.com/resizer/akXvdyvxM4BR-7uY9gtIxiSmqrM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/R4WPXJ5DPJEJ5H3MRMS7MT64EM.jpghttps://insights.citeline.com/in-vivo/market-intelligence/biobytes/evogene-bets-on-autonomous-small-molecule-discovery-TG4D7RXWVJDIXKIFZIXKL63PBE/2026-04-06T17:06:33.841Zalways0.5Insightsen2026-04-06T17:06:33.841Zhttps://insights.citeline.com/resizer/mx6eMXr3O2IBX962vv1M11FoOiA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/6W6F3UFFLNODHAOFO75FTNCPEE.jpghttps://insights.citeline.com/hbw-insight/health/business/strategy/perrigo-isnt-what-it-was-10-years-ago-while-changes-still-demand-more-strategy-shifts-A6AJBKXQXNCAZKXZ6KNDDVQZHM/2026-04-06T16:55:41.223Zalways0.5Insightsen2026-04-06T16:55:41.223Zhttps://insights.citeline.com/resizer/x5SZVAFmQODc_54Ur1yPtOWmu_k=/cloudfront-us-east-1.images.arcpublishing.com/norstella/E6LWODI7QND73EXOWCURIS6TTY.jpghttps://insights.citeline.com/hbw-insight/beauty/business/deals/loreal-closes-kering-beaute-clorox-wraps-purell-beauty-deal-roundup-HBW7BOP37RBETNZULTPTIKSN7U/2026-04-06T15:10:06.771Zalways0.5Insightsen2026-04-06T15:10:06.771Zhttps://insights.citeline.com/resizer/yh-avIEGk3splBMZtHc0NaIwSMU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/EH7B2YMGSNDY7GX4HC3LHKU7SE.jpghttps://insights.citeline.com/hbw-insight/wellness/policy-and-regulation/compliance/us-fda-foods-program-chief-outlines-nimble-and-adaptable-supplement-industry-regulation-PUVPGZFQ2ZEGFLME3NLE5XR7IE/2026-04-06T15:08:01.281Zalways0.5Insightsen2026-04-06T15:08:01.281Zhttps://insights.citeline.com/resizer/3ZKpaOVvGz_ih1c7v7TjK6D5_xE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XZRPRWRW4JD2FLMLYC7AWQITNA.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/vedantas-phase-iii-for-recurrent-c-diff-gets-nod-to-continue-TEP5SSBGHVE7JIG5GSZPIPXG6Y/2026-04-06T13:44:33.181Zalways0.5Insightsen2026-04-06T13:44:33.181Zhttps://insights.citeline.com/resizer/-v7_P5SU53nwWnK4sqcczzfAmIo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/4XMYET2HSZCP5AOVJ35DXGSZIM.jpghttps://insights.citeline.com/hbw-insight/health/business/deals/capvest-has-ambitious-plans-for-stada-as-it-completes-takeover-UZZ3RIBQUBDRHHRFKYXEO2GJ7E/2026-04-06T13:00:16.774Zalways0.5Insightsen2026-04-06T13:00:16.774Zhttps://insights.citeline.com/resizer/C2RqlzLfIifgKysHl5QBuagmt04=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ROHQUM2O2NC2ZCRDMW7WQFQPHU.jpghttps://insights.citeline.com/generics-bulletin/products/biosimilars/thermo-fisher-accelerates-biosimilars-race-with-new-platform-XSGMQDDQMBENZERDPADK3DZKSA/2026-04-06T11:36:31.069Zalways0.5Insightsen2026-04-06T11:36:31.069Zhttps://insights.citeline.com/resizer/cIuZevF1g0HapE5l5Clh7l7pH_s=/cloudfront-us-east-1.images.arcpublishing.com/norstella/F6LQN7OQ2ZANZODRMJUSQXZWA4.jpghttps://insights.citeline.com/generics-bulletin/products/biosimilars/henlius-targets-phesgo-with-next-wave-biosimilar-strategy-5D27ERRGBNHZRAWBVL62ZTUFPE/2026-04-06T10:47:29.629Zalways0.5Insightsen2026-04-06T10:47:29.629Zhttps://insights.citeline.com/resizer/DXqg7P9GVMFh9yyjC42pwGHK6-A=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ZIVQVPAGANJP3CLOP5OMNOU3ZQ.jpghttps://insights.citeline.com/generics-bulletin/business/strategy/xbrane-delays-refiling-ranibizumab-biosimilar-with-us-fda-to-late-spring-3PTKKH7KPJGFXPLZ5AUN3MKLYY/2026-04-06T10:47:22.894Zalways0.5Insightsen2026-04-06T10:47:22.894Zhttps://insights.citeline.com/resizer/5XRoJ6fj5bY2y39VT19CiWBuiGM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/4DSUDX6WNVGXJIZI3WWFEGP3MY.jpghttps://insights.citeline.com/in-vivo/innovation/advanced-therapies/hayas-dark-genome-play-turning-junk-dna-into-drug-targets-3EI7NPDA6FGN5CDS6CVLZRAG3M/2026-04-06T10:14:58.957Zalways0.5Insightsen2026-04-06T10:14:58.957Zhttps://insights.citeline.com/resizer/6NZnZXEACy4IVKllXOkt-GEntjY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XRLPKUHXBVKT7IKKR4XQSJ6HGA.jpghttps://insights.citeline.com/pink-sheet/biosimilars-and-generics/biosimilar-streamlining-takes-a-further-step-forward-in-europe-LEIIFCCRP5FLBL3VLIXML4KMSQ/2026-04-06T07:48:09.496Zalways0.5Insightsen2026-04-06T07:48:09.496Zhttps://insights.citeline.com/resizer/C-kDWasJ-L1HGRfgeEdrX5i4ufs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GGWTS7PAONOYDEX24WQYHJDXGI.jpghttps://insights.citeline.com/pink-sheet/biosimilars-and-generics/generics/hatch-waxman-repairs-could-help-fight-serial-patent-litigations-SCZAB2SCKJG3FHRJNPVPRJYTTI/2026-04-06T07:47:10.856Zalways0.5Insightsen2026-04-06T07:47:10.856Zhttps://insights.citeline.com/resizer/wzdPy2ETYn-NqqEPUBADBmpRiPw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/TE3XOEWQ3JBD5LBYC35VVFZBNA.jpeghttps://insights.citeline.com/pink-sheet/legislation/why-india-is-considering-the-essential-commodities-act-for-pharma-amid-iran-war-E2K4C6TO7FEYHNUTQREDWYJSRI/2026-04-06T06:39:40.22Zalways0.5Insightsen2026-04-06T06:39:40.22Zhttps://insights.citeline.com/resizer/TJtdgk40utzmVNfAaEEtBxxktRQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/YIGANQK24FFZNK5JKFOJEH7IVM.jpghttps://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-HFN7H2ELQBBRHHFQQ2AYFBMXNM/2026-04-06T02:14:12.798Zalways0.5Insightsen2026-04-06T02:14:12.798Zhttps://insights.citeline.com/resizer/yYwvRVmhblLIMA0HOvUK6LfqRwQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/G7XLNG5DWRIZTCTW357HEKFDOE.jpghttps://insights.citeline.com/hbw-insight/wellness/policy-and-regulation/dietary-substance-for-use-by-man-to-supplement-the-diet-open-or-closed-door-for-innovation-3CLUJQ6GQFAPPK2KDV3XWW7AWY/2026-04-06T01:54:29.345Zalways0.5Insightsen2026-04-06T01:54:29.345Zhttps://insights.citeline.com/resizer/pFTuDXtZ3a2s0UbFSka0IM7PseM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/CPG2S5V5KZD4PDQN2AUBAWKCSU.jpghttps://insights.citeline.com/companies/hopitaux-universitaires-de-geneve2026-04-06T00:01:10.225Zalways0.5Insightsen2026-04-06T00:01:10.225Z